Background: Class I human leukocyte antigen (HLA) molecule contributes to the immune control of HIV through antigen presentation to both cytotoxic T lymphocytes (CTL) and natural killer cells (NK). CTL contribution to HIV control through antigen presentation by protective HLA alleles, such as HLA-B*57 and HLA-B*27, has been studied well previously. However, reports on the NK cell contribution, with the exception of the protective effect of HLA-Bw4 and its ligand killer immunoglobulin-like receptor (KIR) 3DL1 and 3DS1 in HIV disease, are limited. In particular, studies about HLA-C-KIR2D on HIV control remain sparse.
Methods: 209 HIV-1 CRF01_AE-infected treatment-naïve Thais were recruited, and the effects of HLA-C-KIR2D on clinical outcome were statistically analyzed.
Results: 1) HLA-B*46:01, which worked as an HLA-C1 allele binding the same type of ligands despite being an HLA-B allele, was identified as the most predominant HLA-B allele (29% in the population frequency). 2) In the analysis of the viral set point difference among HLA-C1-positive individuals, subjects with KIR2DL3 had significantly higher set point compared to the subjects without KIR2DL3 (median 4.8 vs 4.2 log copies/ml, p=0.033 by Mann-Whitney U-test). 3) In multivariate analysis, the number of HLA-C1-KIR2DL3 associations (ranging from subjects having no HLA-C1-KIR2DL3 associations to subjects having up to four combinations; the KIR2DL3-positive individuals with HLA-B*46:01 homozygous and HLA-C1 allele homozygous) was identified as a significant viral load predictor (β=0.13, p=0.039 by linear regression model). 4) In longitudinal analysis, higher mortality rate was identified among the subjects with higher number of HLA-C1-KIR2DL3 associations (p=0.002 by log rank test; aHR=2.0, 95% CI 1.3-3.2, p=0.004 by Cox hazard model) (Figure). 5) However, no advantage of HLA-Bw4-KIR3DL1/S1 on clinical outcome was found in this cohort.
Conclusions: In this study, the effects of HLA-C and KIR2D interaction with a focus on the effect of the detrimental HLA-C1-KIR2DL3 association, on clinical outcome among HIV-1 CRF01_AE-infected Thais were investigated. These findings will impact the existence of the unique anti-HIV innate immune pressure and viral adaptation to such pressure in each endemic area.
Figure. The number of KIR2DL3-ligand HLA associations and survival rate analysis, log rank test.